
    
      Part A

        -  To assess the safety and tolerability of single ascending oral doses of FB-101 in
           healthy subjects.

        -  To assess the pharmacokinetics (PK) of single ascending oral doses of FB-101 in healthy
           subjects.

        -  To assess the effect of a high-fat meal on the PK of a single oral dose of FB-101 when
           administered to healthy subjects.

      Part B

        -  To assess the safety and tolerability of multiple ascending oral doses FB-101 in healthy
           subjects.

        -  To assess the PK of multiple ascending oral doses of FB-101 in healthy subjects.
    
  